Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$60,705,174
-$19,383,696 QoQ
Shares Held
3,822,744
-40.6% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 1,016 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
This page
|
3,822,744 | $60,705,174 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,705,174 | 3,822,744 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $80,088,870 | 6,432,841 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $103,093,456 | 11,544,620 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $108,705,337 | 12,480,521 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $142,590,659 | 11,453,065 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $128,603,168 | 11,076,931 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $134,435,834 | 12,646,833 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $153,885,609 | 12,888,242 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $126,181,196 | 11,651,080 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $114,523,791 | 11,614,989 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $115,548,170 | 11,577,973 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $106,254,487 | 11,045,165 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $125,413,062 | 11,268,020 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $88,522,067 | 10,389,914 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $101,309,656 | 9,676,185 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $87,371,970 | 8,030,512 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $109,930,154 | 8,124,919 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $120,392,847 | 8,885,081 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $156,830,592 | 10,974,849 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $154,921,781 | 11,089,605 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $205,090,222 | 10,943,982 | Shares | Sole | 2021-03-02 | |
| No filing history on record for this holder in this stock. | ||||||